Transcranial Magnetic Stimulation (TMS) for Trigeminal Neuralgia (NCT04120129) | Clinical Trial Compass
UnknownNot Applicable
Transcranial Magnetic Stimulation (TMS) for Trigeminal Neuralgia
United States51 participantsStarted 2020-08-01
Plain-language summary
The primary objective is to establish the feasibility of using TMS for COFP pain management in the interim period before surgery. This will be investigated by comparing the non-intervention group's self-reported pain to those who recieved TMS at several timepoints.
Who can participate
Age range18 Years – 100 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Documented diagnosis of classic trigeminal neuralgia or persisten idiopathic facial pain
* Considered an appropriate candidate for surgical or stereotactic intervention - microvascular decompression or stereotactic radiosurgery- ( includes factors such as overall health, chronic medication, comorbidities) and patient preference
* Between ages 18-100
* Able to participate in 5 consecutive TMS treatments
* Has at least 3 weeks between pre-op visit and scheduled date of surgery
* Able to provide consent and complete online questionnaires on their own
Exclusion Criteria:
* Multiple Sclerosis or trauma-related etiology of facial pain (i.e. secondary facial pain)
* contraindication to TMS, per device guidelines:
Metallic implant in or near head Implanted stimulator on or near head recent suicidal ideation history of epilepsy, stroke, or unexplained seizure
\- Need for urgent/emergent surgical decompression.